Clipster® Aseptic Disconnector makes aseptic tubing disconnection easy
Goettingen, Germany / Aubagne, France , March 26, 2013 / B3C newswire / -Sartorius Stedim Biotech, a leading international supplier for the pharma and biotech industries, has launched new sizes XS and S of the Clipster® Aseptic Disconnector, in addition to the existing size L. This single-use device allows an aseptic disconnection of Silicone (Pt) as well as thermoplastic elastomer (TPE) tubes in biopharmaceutical manufacturing processes. It is safe, quick, easy to use and available as a stand-alone product or pre-mounted on single-use transfer lines and bag assemblies.
The Clipster® Aseptic Disconnector is used after a fluid transfer to disconnect transfer lines and bag assemblies. The disconnection of tubes can be performed in non-classified and classified environments while maintaining product sterility. It is performed with a hand-held tool which ensures easy execution in various space requirements. The Clipster® Aseptic Disconnector XS, S or L can be applied to multiple tubing material (silicone and TPE) and sizes from 1/8”x1/4” up to 1/2” x 3/4”.
The validation of this key single-use device has been carried out under the most stringent test regimes. Biological and physical tests have been combined to provide data representing a variety of process conditions including critical applications.
Caption: The Clipster® Aseptic Disconnector XS (yellow), S (red) and L (white) is used after a fluid transfer to disconnect single-use transfer lines and bag assemblies made of silicone or TPE tubes.
(For high resolution picture please right click the image and select "Save target as...")
A Profile of Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of “turning science into solutions”. Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs around 3,000 people and in 2012 earned sales revenue of 544 million euros.
Sartorius Group Corporate Communications
Phone: +49.(0)551. 308.3324